Geode Capital Management’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
CAM
BL
S
MFIM
Geode Capital Management's ICCC Position: Q2 2026 in Review
Geode Capital Management increased its ImmuCell (ICCC) stake by 9.9% in Q2 2026, buying an estimated $57.5K and bringing the position to 72,270 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #3467.
Geode Capital Management first reported a position in ICCC in Q1 2020 and has held it in 26 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.
- Geode Capital Management held 72,270 shares of ImmuCell worth $726K as of Q2 2026.
- Geode Capital Management bought 6,505 ImmuCell shares in Q2 2026, an estimated $57.5K.
- ImmuCell made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3467 holding.
- Geode Capital Management first reported a position in ImmuCell in Q1 2020 and has held it in 26 quarters since.
- 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.